Patent Assignment
Reel/Frame 059927/0083
Assignment of Assignor's Interest
Recorded: 2022-05-17
Pages: 3
Assignor
ERBE, DAVID V.
Executed: 2018-07-19
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142-1110
Covered Property
(1)
Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression
Application:
17/579,655 →
Publication:
US 2022/0403394
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.